EquityZen Growth Technology Fund LLC - Series 1901
Raised
$3M
Investors
91
Min Invest
$1,016
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1901 is a Delaware LLC filed by EquityZen Advisors and Philip Haslett, raising $2.5M from 91 investors under Rule 506(b) and Section 3(c)(1). The minimum investment is $1K. This is part of EquityZen's platform of 1889 related entities providing pre-IPO secondary market access through serialized SPVs.
This pre-IPO pooled investment fund uses the standard 506(b)/3(c)(1) exemption pattern for private placement vehicles with under 100 beneficial owners. The $1K minimum investment is characteristic of retail-accessible secondary market platforms, substantially lower than typical institutional pre-IPO funds which often require $100K+ minimums.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
